EAM Global Investors’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-101,882
Closed -$984K 124
2023
Q1
$984K Sell
101,882
-285,968
-74% -$2.49M 0.28% 81
2022
Q4
$2.94M Buy
387,850
+10,245
+3% +$69.4K 0.76% 32
2022
Q3
$2.28M Buy
+377,605
New +$2.42M 0.61% 49
2019
Q4
Sell
-368,986
Closed -$2.55M 149
2019
Q3
$2.55M Buy
+368,986
New +$2.46M 1.24% 18

Other funds holding VMD

EAM Global Investors's VMD Position: Q2 2023 in Review

EAM Global Investors sold out of Viemed Healthcare (VMD) in Q2 2023, closing a stake of 101,882 shares — an estimated $984K sold.

EAM Global Investors first reported a position in VMD in Q3 2019 and held it in 4 quarters. The position peaked at $2.94M in Q4 2022. 103 funds tracked by Wall St. Rank hold VMD as of Q2 2023.

  • EAM Global Investors reported no remaining Viemed Healthcare position as of Q2 2023 after selling out during the quarter.
  • EAM Global Investors sold 101,882 Viemed Healthcare shares in Q2 2023, an estimated $984K.
  • EAM Global Investors first reported a position in Viemed Healthcare in Q3 2019 and held it in 4 quarters.
  • EAM Global Investors's Viemed Healthcare position peaked at $2.94M in Q4 2022.
  • 103 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2023.

Based on EAM Global Investors's 13F filing for Q2 2023, filed 11 Aug 2023.